Jeffrey Townsend

@jeffreytownsend.bsky.social

Elihu Professor of Biostatistics @yalesph.bsky.social--Evolutionary biology of cancer, infectious disease, and fungi; sometimes running.

SARS-CoV-2 did not come from a lab. There is no evidence pointing to laboratory origins. There’s been a massive disinformation campaign to convince the public otherwise. It’s scary how effective that campaign has been.

Just published in Journal of Translational Medicine: we investigate mutations driving colon and rectal adenocarcinomas. Deconvolution into mutational supply and selection motivates anatomical specification with BRAF and PIK3CA hotspot status. 🧪 link.springer.com/article/10.1...

A comparative mutation–selection reanalysis of colon and rectal adenocarcinoma highlights PIK3CA variants and BRAF V600E - Journal of Translational Medicine

Journal of Translational Medicine -

link.springer.com

The Trump Administration is sending billions to Amazon, Apple, Walmart, and other big corporations to refund them for Trump’s tariffs. American households were estimated to lose over $1,000 to tariff price hikes. Here's an idea: refund working families before big business.

Cannot be more excited about the lineup for the inaugural Function of Evolving Systems GRC conference I am co-organizing with the amazing Joy Bergelson. Less than a month away: August 9 - 14, 2026. Still a few spots left! And do check out the amazing list of speakers: www.grc.org/function-of-...

2026 Function of Evolving Systems Conference GRC

The 2026 Gordon Research Conference on Function of Evolving Systems will be held in Waterville Valley, New Hampshire. Apply today to reserve your spot.

grc.org

Tumor driver co-mutation patterns are not conclusions—they are hypotheses. Mutual exclusivity/co-occurrence in cancer genomes become biologically meaningful (i.e. informative of epistasis) only when evaluated in the context of mutation-rate heterogeneity. 🧪: onlinelibrary.wiley.com/doi/10.1002/...

Empowering Inference of Epistasis on the Basis of Mutual Exclusivity, Co‐Occurrence, Functional Antagonism and Synergy in ERK‐Pathway Oncogenes

Click on the article title to read more.

onlinelibrary.wiley.com

2/n Intramolecular epistasis is increasingly recognized as an important feature of adaptive protein evolution. But how do adaptive amino acid substitutions actually accumulate? Do epistatically interacting substitutions fix sequentially, or do favorable combinations assemble before fixation?

Politics is entitled to determine the topics and targets for public investment of funds. But the science to be done to accomplish those goals is best decided on by scientists. White House seeks to tighten political oversight of grantmaking | Science | AAAS www.science.org/content/arti...

White House seeks to tighten political oversight of grantmaking

Sweeping proposed rule, now open for comments, would also restrict foreign collaborations and remove federal funding for open-access fees

science.org

Every cancer case can be associated with a genetic “fingerprint” shaped by both inherited vulnerabilities and acquired mutations. @yalemedicine.bsky.social: an open-access tool to quantify pathway-level disruption and advance personalized cancer risk assessment. medicine.yale.edu/news-article...

Calculating Cancer Risk Through the Genetic Fingerprints of Tumors

A new tool offers insights into understanding why every patient has a unique cancer journey.

medicine.yale.edu

Older adults benefit from COVID-19 vaccine protection that keeps pace with waning immunity. Nursing home resident data show that antibodies decline substantially over the 12 months after vaccination, supporting biannual vaccine updates for adults 65+. www.sciencedirect.com/science/arti...

Antibody responses to SARS-CoV-2 vaccine in nursing home residents support a Bi-annual update schedule

The COVID-19 pandemic has greatly affected nursing home residents (NHRs), a vulnerable group with high rates of illness and death. While vaccination i…

sciencedirect.com

· #mRNAvaccine · The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel Prize–winning technology is being adapted to fight cancer, with mRNA vaccines in clinical trials for melanoma, small-cell lung cancer and bladder cancer, among others…

How mRNA cancer vaccines still destroy tumors when a key immune cell is missing

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel Prize–winning technology is being adapted to fight cancer, with mRNA vaccines in clin...

medicalxpress.com

The U.S. could cut outpatient prescription drug spending by $184 billion per year—a 51% reduction—by aligning prices with those in peer high-income nations. Drug affordability is a policy choice, not an inevitability. ysph.yale.edu/news-article...

Yale study: U.S. could save $184 billion by aligning drug prices with peer nations

Researchers at the Yale School of Public Health estimate that the United States could reduce its annual spending on outpatient prescription drugs by $184

ysph.yale.edu

This is how we do it. 1. Win majorities in the House and Senate. 2. Impeach and remove DJT 3. Impeach and remove JDV 4. Democratic Speaker of the House becomes President. 5. Prosecute, convict, and imprison every one of DJTs cabal 6. Send a message to the world that we can throw out the trash